Combined anti-platelet therapy with aspirin and clopidogrel: Risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Authors:
- Imanuel DzialowskiIDImanuel Dzialowski
- Roland KochRKRoland Koch
- Georg GahnGGGeorg Gahn
- 15 September 2009
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 284 (1-2) , 155-157
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?The American Journal of Cardiology, 2009
- Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled TrialsStroke, 2008
- Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic StrokeArchives of Neurology, 2008
- Risk Factors of Symptomatic Intracerebral Hemorrhage After tPA Therapy for Acute StrokeStroke, 2007
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialThe Lancet, 2006
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic EventsNew England Journal of Medicine, 2006
- Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 2004
- Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical PracticeCirculation, 2002
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995